首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD31 Antibody
产品名称:
PE/Cyanine7 anti-mouse CD31 Antibody
产品类别:
抗体
产品编号:
102417
产品应用:
102417
[价格]
规格 价格 库存
25µg ¥ 1212 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/HeJ mouse hematopoietic progenitor cell line 3
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Anti-mouse CD31 clones 390 and MEC13.3 bind to their respective non-overlapping epitopes in IgD2 of CD31.8 Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo blocking of CD31-mediated cell-cell interactions1-4, and immunohistochemical staining5,6,7 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Special Note: This antibody is not recommended for formalin-fixed paraffin-embedded sections. The LEAF? purified antibody (Endotoxin < 0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 102412).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Baldwin HS, et al. 1994. Development 120:2539. (IP, Block)
  2. DeLisser HM, et al. 1997. Am. J. Pathol. 151:671. (Block)
  3. Rosenblum WI, et al. 1996. Stroke 27:709. (Block)
  4. Iguchi A, et al. 1997. Cell Struct. Funct. 22:357. (Block)
  5. Wyder L, et al. 2000. Cancer Res. 60:4682. (IHC)
  6. Wiewrodt R, et al. 2002. Blood 99:912. (IHC)
  7. McQualter JL, et al. 2009. Stem Cells. 27:623. (IHC) PubMed
  8. Chacko AM, et al. 2012. PLoS One 7:e34958.
  9. Greineder CF, et al. 2013. PLoS One. 14:80110. PubMed
Product Citations
  1. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  2. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  3. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  4. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  5. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  6. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  7. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  8. Hu X, et al. 2016. Nat Commun. 7:13095. PubMed
  9. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  10. Fu X, et al. 2015. J Biol Chem. 290: 26445 - 26456. PubMed
  11. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  12. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  13. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  14. Minatoguchi S, et al. 2022. Sci Rep. 12:5389. PubMed
  15. Han YH, et al. 2021. Science. 373:. PubMed
  16. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  17. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  18. Solanas G, et al. 2017. Cell. 170:678. PubMed
  19. Plein A, et al. 2018. Nature. 562:223. PubMed
  20. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  21. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  22. Duan L, et al. 2021. Immunity. 54:2256. PubMed
  23. Reddy A, et al. 2020. Cell. 183:62. PubMed
  24. Kumar B, et al. 2020. Haematologica. Online ahead of print:. PubMed
  25. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  26. Ni C, et al. 2022. Nat Commun. 13:5919. PubMed
  27. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  28. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  29. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  30. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  31. Zink J, et al. 2021. EMBO Rep. 22:e48961. PubMed
  32. Gordon E, et al. 2010. Development. 137:3899. PubMed
  33. Linnerbauer M, et al. 2022. JCI Insight. 7:. PubMed
  34. Su Y, et al. 2020. Cell Death Differ. 949:27. PubMed
  35. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  36. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  37. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  38. Cheng HW, et al. 2022. Nat Commun. 13:2027. PubMed
  39. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  40. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  41. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  42. Schw?rer S, et al. 2016. Nature. 540:428-432. PubMed
  43. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  44. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  45. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  46. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  47. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  48. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  49. Geng Y, et al. 2022. Nat Commun. 13:7114. PubMed
  50. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  51. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  52. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  53. Zhuo X, et al. 2021. Biomed Rep. 15:64. PubMed
  54. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  55. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  56. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  57. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  58. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  59. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  60. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  61. Cui Y, et al. 2020. Eur J Pharmacol. 881:173233. PubMed
  62. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  63. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
RRID
AB_830756 (BioLegend Cat. No. 102417) AB_830757 (BioLegend Cat. No. 102418)

Antigen Details

Structure
Ig superfamily, 130-140 kD
Distribution

Endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, T and B cell subsets

Function
Adhesion
Ligand/Receptor
CD38, αV3 integrin
Cell Type
B cells, Dendritic cells, Endothelial cells, Granulocytes, Macrophages, Monocytes, Neutrophils, Platelets, T cells
Biology Area
Angiogenesis, Cell Adhesion, Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. DeLisser HM, et al. 1994. Immunol. Today 15:490.
3. Newman PJ, et al. 1990. Science 247:1219.

Gene ID
18613 View all products for this Gene ID
UniProt
View information about CD31 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线